GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

Home・Aandelen Lijst・BioArctic AB

B
BioArctic AB

Gesloten

290 -7.29

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

272.2

Max

312.8

Belangrijke statistieken
By Trading Economics
Inkomsten	-979M 97M
Verkoop	-897M 392M
K/W Sectorgemiddelde	25.665 35.733
EPS	1.09
Winstmarge	24.623
Werknemers	119
EBITDA	1.1B 1.1B

Marktinformatie
By TradingEconomics
Marktkapitalisatie	6.6B 27B
Vorige openingsprijs	297.29
Vorige sluitingsprijs	290

BioArctic AB Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

5 sep 2025, 16:09 UTC

Acquisities, Fusies, Overnames

BBVA Clears Last Hurdle to Open $17.4 Billion Bid to Sabadell Shareholders -- 2nd Update

5 sep 2025, 20:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

5 sep 2025, 20:37 UTC

Acquisities, Fusies, Overnames

Blue Water: Assets of Auction Include Nationwide Retail Distribution Network of More Than 4,000 Branded Service Stations >BLUWU

5 sep 2025, 20:37 UTC

Acquisities, Fusies, Overnames

Blue Water: Assets of Auction Include Lubricant and Blending Plants Supporting Specialty Fuels and Lubricants >BLUWU

5 sep 2025, 20:36 UTC

Acquisities, Fusies, Overnames

Blue Water: Assets of Auction Include Midstream Infrastructure, Including Pipelines and Terminals Such as the Sour Lake Crude Pipeline >BLUWU

5 sep 2025, 20:36 UTC

Acquisities, Fusies, Overnames

Blue Water: Assets of Auction Include Refineries at Lake Charles, La., Lemont, Ill., Corpus Christi, Texas, With Combined Refining Capacity Exceeding 800,000 Barrels per Day >BLUWU

5 sep 2025, 20:33 UTC

Acquisities, Fusies, Overnames

Blue Water: Proposal Would Provide $3.2B Settlement for Holders of PDVSA 2020 Bonds to Be Paid Either in Cash or in Shrs of Publicly Listed Entity That Will Own Citgo >BLUWU

5 sep 2025, 20:33 UTC

Acquisities, Fusies, Overnames

Blue Water: Proposal Would Provide Cash or Stk Distributions to PDV Holding Inc.'s General Creditors >BLUWU

5 sep 2025, 20:31 UTC

Acquisities, Fusies, Overnames

Blue Water Acquisition Corp. III: Announces Submission of $10B Bid for PDV Holding Inc., Parent of Citgo Petroleum Corp.

5 sep 2025, 20:20 UTC

Winsten

These Stocks Moved the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Kenvue, Guidewire, and More -- Barrons.com

5 sep 2025, 19:23 UTC

Marktinformatie

Oil Futures Extend Losses Ahead of OPEC+ Meeting -- Market Talk

5 sep 2025, 19:22 UTC

Winsten

Week's Best: Insurance Costs, Like Sea Levels, Are Rising -- Barrons.com

5 sep 2025, 19:17 UTC

Marktinformatie

U.S. Natural Gas Snaps Winning Streak -- Market Talk

5 sep 2025, 18:59 UTC

Winsten

These Stocks Are Moving the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Kenvue, Guidewire, and More -- Barrons.com

5 sep 2025, 18:35 UTC

Marktinformatie

BMO Leans Toward September Canada Rate Cut After 'Exceptionally Weak' Jobs Report -- Market Talk

5 sep 2025, 17:25 UTC

Marktinformatie

Bets on Hefty Fed Cut Seen as Exaggerated -- Market Talk

5 sep 2025, 17:20 UTC

Marktinformatie

U.S. Oil Rig Count Rises By 2 to 414 -- Market Talk

5 sep 2025, 17:17 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

5 sep 2025, 17:17 UTC

Marktinformatie

Bank of Canada Policy Seen Moving to Expansionary Territory -- Market Talk

5 sep 2025, 17:03 UTC

Marktinformatie

Bank of Canada Expected to Cut, But Inflationary Pressures Remain a Concern -- Market Talk

5 sep 2025, 16:39 UTC

Acquisities, Fusies, Overnames

Yorkville Acquisition: Commencing at Market Open on Sept 8, Common Stk Will Trade on Nasdaq Under New Ticker Symbol 'MCGA' >YORK

5 sep 2025, 16:39 UTC

Acquisities, Fusies, Overnames

Yorkville Acquisition: Will Be Renamed to Trump Media Group CRO Strategy Upon Closing of Combination Between Yorkville, Trump Media & Technology Group Corp. and Crypto.com >YORK

5 sep 2025, 16:39 UTC

Acquisities, Fusies, Overnames

Yorkville Acquisition Corp.: Announces Ticker Symbol Change to 'MCGA' Ahead of Trump Media Group CRO Strategy, Inc. Listing

5 sep 2025, 16:39 UTC

Acquisities, Fusies, Overnames

Yorkville Acquisition: Outstanding Publicly Traded Units and Warrants Will Trade on Nasdaq Under New Ticker Symbols 'MCGAU' and 'MCGAW', Respectively >YORK

5 sep 2025, 16:37 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Global Equities Roundup: Market Talk

5 sep 2025, 16:37 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Global Energy Roundup: Market Talk

5 sep 2025, 16:37 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Strathcona Buys Up More MEG Shares In Effort to Scuttle Cenovus Deal -- Market Talk

5 sep 2025, 16:20 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

5 sep 2025, 16:16 UTC

Winsten

These Stocks Are Moving the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Guidewire, and More -- Barrons.com

5 sep 2025, 16:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

Peer Vergelijking

Prijswijziging

BioArctic AB Prognose

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.